All News antibody In Focus antibody BreakingNews of antibody Your Interested Follow Story antibody

First batch of long-acting antibody drug arrives next week
TUESDAY, JULY 19, 2022
The first batch of the long-acting antibody drug Evusheld will arrive in Thailand next Monday and will be immediately administered to kidney failure and organ transplant patients, the Public Health Ministry said.
Study shows mRNA-based COVID-19 antibody provides long-term protection in mice
THURSDAY, MARCH 03, 2022
Chinese researchers have developed an mRNA antibody that provided long-term protection against SARS-CoV-2 in animal tests, representing a promising antibody-based therapy for COVID-19 patients.
Astra Covid booster increases antibodies against omicron
FRIDAY, DECEMBER 24, 2021
A third dose of AstraZenecas Covid-19 vaccine significantly boosted neutralizing antibodies against omicron, according to lab studies at the University of Oxford.
AstraZeneca publishes more positive data on Covid antibody treatment
THURSDAY, NOVEMBER 18, 2021
AstraZenecas Covid-19 antibody cocktail was more than 80% successful at both preventing symptomatic disease for six months and stopping the illness from worsening, demonstrating its ability to provide strong and long-lasting protection.
Antibody levels reduce quickly even after 2 vaccine doses: Swedish study
WEDNESDAY, SEPTEMBER 29, 2021
More than 2,000 hospital employees were observed for the study, and the latest findings were based on a subset of more than 460 staff, Swedish Television reported.
Vaccine recipients urged to avoid using antibody kits for self-testing
SATURDAY, JUNE 26, 2021
The Department of Medical Sciences has advised people against buying antibody testing kits to test themselves after getting a Covid-19 vaccine, as the result could be inaccurate and might cause misunderstanding.
Celltrion presents COVID-19 antibody pipeline’s phase 1 trial results to Korean doctors
FRIDAY, NOVEMBER 06, 2020
Celltrion reaffirmed positive findings from the phase 1 clinical trial of its COVID-19 antibody treatment CT-P59 at the annual autumn conference of Korean societies of infectious diseases and antimicrobial therapy, the company said Friday.